Regeneron Ventures
Regeneron Pharmaceuticals, Inc. is a prominent American biotechnology company based in Tarrytown, New York. Founded in 1988 by Nobel laureate Alfred G. Gilman and others, Regeneron focuses on the development of innovative medicines for serious diseases. The company operates as a fully integrated biopharmaceutical enterprise, engaging in research, development, manufacturing, and commercialization of its products. Regeneron is well-known for its advanced biologics, including monoclonal antibodies and VEGF-traps. Its key products address various medical conditions, such as EYLEA for eye diseases
Investing activity
Regeneron Ventures is listed on AI Lounge as a corporate investor based in Tarrytown, New York, United States. The deals desk records Series A and later AI rounds and seeds over $10M, so smaller checks may not show here yet.
Deals
Frequently asked questions about Regeneron Ventures
Where is Regeneron Ventures based?
Regeneron Ventures is based in Tarrytown, New York, United States.
How can founders reach Regeneron Ventures?
Founders on AI Lounge can see Regeneron Ventures's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with the firm under Warm Paths, and add Regeneron Ventures to their Investor Pipeline to track the conversation.